Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response

NCT01128803 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE: injection of the cell therapy product

Sponsor

Nantes University Hospital